Therapeutic inhibition of the complement system in diseases of the central nervous system

SM Carpanini, M Torvell, BP Morgan - Frontiers in immunology, 2019 - frontiersin.org
The complement system plays critical roles in development, homeostasis, and regeneration
in the central nervous system (CNS) throughout life; however, complement dysregulation in …

The hallmarks of P arkinson's disease

PMA Antony, NJ Diederich, R Krüger… - The FEBS …, 2013 - Wiley Online Library
Since the discovery of dopamine as a neurotransmitter in the 1950s, P arkinson's disease
(PD) research has generated a rich and complex body of knowledge, revealing PD to be an …

Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration

KL Paumier, KC Luk, FP Manfredsson… - Neurobiology of …, 2015 - Elsevier
Previous studies demonstrate that intrastriatal injections of fibrillar alpha-synuclein (α-syn)
into mice induce Parkinson's disease (PD)-like Lewy body (LB) pathology formed by …

Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease

JM Taylor, BS Main, PJ Crack - Neurochemistry international, 2013 - Elsevier
Parkinson's disease (PD) is a complex disease, with genetics and environment contributing
to the disease onset. Recent studies of causative PD genes have confirmed the involvement …

Innate and adaptive immune responses in Parkinson's disease

AM Schonhoff, GP Williams, ZD Wallen… - Progress in brain …, 2020 - Elsevier
Parkinson's disease (PD) has classically been defined as a movement disorder, in which
motor symptoms are explained by the aggregation of alpha-synuclein (α-syn) and …

Animal models of Parkinson's disease: An updated overview

P Gubellini, P Kachidian - Revue neurologique, 2015 - Elsevier
Parkinson's disease (PD) is a progressive neurodegenerative disorder whose etiology,
besides a minority of genetic cases, is still largely unknown. Animal models have contributed …

Longitudinal in vivo metabolic labeling reveals tissue-specific mitochondrial proteome turnover rates and proteins selectively altered by parkin deficiency

KL Stauch, S Totusek, AJ Trease, LD Estrella… - Scientific reports, 2023 - nature.com
Our study utilizes a longitudinal isotopic metabolic labeling approach in vivo in combination
with organelle fraction proteomics to address the role of parkin in mitochondrial protein …

New developments in genetic rat models of Parkinson's disease

RB Creed, MS Goldberg - Movement Disorders, 2018 - Wiley Online Library
Preclinical research on Parkinson's disease has relied heavily on mouse and rat animal
models. Initially, PD animal models were generated primarily by chemical neurotoxins that …

The mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice

LJ Martin, S Semenkow, A Hanaford, M Wong - Neurobiology of aging, 2014 - Elsevier
Parkinson's disease (PD) is a movement disorder caused by neurodegeneration in
neocortex, substantia nigra and brainstem, and synucleinopathy. Some inherited PD is …

Strategies for manipulating microglia to determine their role in the healthy and diseased brain

B Parajuli, S Koizumi - Neurochemical Research, 2023 - Springer
Microglia are the specialized macrophages of the central nervous system and play an
important role in neural circuit development, modulating neurotransmission, and maintaining …